Thus, HDAC1 may regulate the progression of breast cancer and associated metastasis, and inhibition of HDAC1 emerges as a promising therapeutic target for cancer therapy (Senese et al., 2007; Uba and Yelekçi, 2017). This evidence concerns the gene HDAC1 and breast carcinoma.